Want to see JRVR full AI Analyst Report?
Top Page
James River Group
(NASDAQ:JRVR)
Select Model
Select Model
Rating:59Neutral
Price Target:
$4.50
▼(-4.46% Downside)
Action:Reiterated
Date:08/11/26
JRVR scores as a moderate opportunity primarily because financial performance is improving but still uneven, with negative recent free cash flow and modest top-line contraction tempering the earnings rebound. Valuation is a key positive (low P/E), while technical indicators are neutral and the earnings call supports gradual progress (better E&S underwriting and lower expenses) but highlights ongoing pressure from breakeven consolidated underwriting and shrinking premium volumes.
Positive Factors
E&S Underwriting Improvement
Sustained E&S combined ratio improvement to 92.8% reflects stronger risk selection and pricing in the company’s core specialty book. Over 2–6 months this supports durable earnings quality, reduces volatility from loss creep, and gives management room to prioritize profitable growth rather than volume.
Negative Factors
Consolidated Underwriting Breakeven
A company-wide combined ratio near 100% implies underwriting is effectively breakeven after expenses. This limits internal capital generation from core operations, making earnings reliant on investment returns and exposing results to adverse loss development or pricing deterioration over the medium term.
Read all positive and negative factors
Positive Factors
Negative Factors
E&S Underwriting Improvement
Sustained E&S combined ratio improvement to 92.8% reflects stronger risk selection and pricing in the company’s core specialty book. Over 2–6 months this supports durable earnings quality, reduces volatility from loss creep, and gives management room to prioritize profitable growth rather than volume.
Read all positive factors
James River Group Key Performance Indicators (KPIs)
Any
Revenue by Segment
Breaks down total revenue by business segment — including earned premiums, fee income, and investment-related income — to show what actually drives the company’s top line. Comparing segments helps investors understand whether earnings are coming from core underwriting, investment returns, or ancillary fees, and where concentration or scalability risks exist.
Breaks down total revenue by business segment — including earned premiums, fee income, and investment-related income — to show what actually drives the company’s top line. Comparing segments helps investors understand whether earnings are coming from core underwriting, investment returns, or ancillary fees, and where concentration or scalability risks exist.
Data provided by:
The Fly
James River Group (JRVR) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$217.31M
Dividend Yield0.88%
Average Volume (3M)262.99K
Price to Earnings (P/E)8.4
Beta (1Y)0.77
Revenue Growth-1.78%
EPS GrowthN/A
CountryUS
Employees577
SectorFinancial
Sector Strength70
IndustryInsurance - Specialty
Share Statistics
EPS (TTM)0.54
Shares Outstanding46,236,855
10 Day Avg. Volume246,814
30 Day Avg. Volume262,986
Financial Highlights & Ratios
PEG Ratio-0.05
Price to Book (P/B)0.44
Price to Sales (P/S)0.43
P/FCF Ratio-12.39
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price Target
$4.75Price Target Upside0.85% Upside
Rating ConsensusHold
Number of Analyst Covering1
EPS Forecast (FY)0.83
Revenue Forecast (FY)$541.20M
James River Group Business Overview & Revenue Model
Company Description
James River Group Holdings, Ltd. operates as an insurance holding company, delivering specialized insurance and reinsurance offerings across the United States through its subsidiary companies. Its business activities are divided into three main op...
How the Company Makes Money
JRVR generates earnings primarily through (1) underwriting income and (2) investment income on its insurance float.
1) Underwriting (premium-based revenue)
- Premiums: The company sells insurance policies and collects premiums upfront. Premium vo...
James River Group Earnings Call Summary
Earnings Call Date:Aug 10, 2026
(Q2-2026)
| % Change Since: |
Next Earnings Date:Nov 03, 2026
Earnings Call Sentiment Neutral
The call presents a mix of constructive progress and ongoing challenges. Key positives include improved underwriting performance in the core E&S segment (92.8% combined ratio), substantive expense reductions (G&A down 9% YTD; specialty admitted expenses down ~39%), higher net premium retention (+9 points to 55%), increased submission and quote activity, stable net investment income ($20.3M), and improving reserve development in recent accident years. Offsetting these are a consolidated combined ratio of 100.2% (company-wide underwriting roughly breakeven), lower operating earnings and EPS, materially lower premium volumes and average account size (average premium down ~22.9% YoY) due to intentional runoffs and non-renewals, and heightened competition and pricing pressure in property and general casualty. Overall, the company emphasizes a deliberate shift to prioritize profitability over volume and appears positioned defensively, leaving a cautiously balanced outlook.Positive Updates
E&S Underwriting Profitability Improved
E&S segment achieved a 92.8% combined ratio this quarter, an improvement from 96.5% last quarter, demonstrating meaningful underwriting progress in the core portfolio.
Negative Updates
Consolidated Underwriting Breakeven
The consolidated combined ratio was 100.2% for the quarter (66.3% loss ratio, 33.9% expense ratio), indicating roughly breakeven underwriting performance company-wide despite E&S profitability.
Read all updates
Q2-2026 Updates
Positive
Negative
E&S Underwriting Profitability Improved
E&S segment achieved a 92.8% combined ratio this quarter, an improvement from 96.5% last quarter, demonstrating meaningful underwriting progress in the core portfolio.
Read all positive updates
Company Guidance
Management's guidance emphasized prioritizing underwriting profitability over near‑term volume and steering capacity to higher risk‑adjusted returns while cutting expenses and running off noncore admitted business; key metrics cited included an E&S combined ratio of 92.8% (vs. 96.5% last quarter) and consolidated combined ratio of 100.2% (loss ratio 66.3%, expense ratio 33.9%), gross net premium retention up 9 points to 55% (from 47% YoY), submissions for active divisions +4% with quotes on new business +4% and 10 of 13 divisions quoting more, average account premium down 22.9% YoY, net income to common $4.4M (+59% YoY), operating earnings $10M ($0.20/sh) vs $11.7M ($0.23) prior, annualized operating ROTCE 10%, tangible common book value per share $9.01, G&A down 9% YTD (quarter G&A -$2.5M or -7%), specialty admitted expense base reduced >40% YTD (specialty admitted now ~25% of NII), net investment income $20.3M, realized/unrealized gains ~$1M, ~75% of invested assets in high‑grade fixed income (avg. duration 3.6 years, A+), total net reserves $1.05B ($950M E&S, >$800M in 2024–26 years), legacy reserve cover bolstered reserves by ~$235M over two years, and the E&S reinsurance treaty was renewed with modest changes — collectively signaling targeted, capital‑light growth (specialty E&S, excess casualty, small business), continued expense discipline, and reserve and balance‑sheet protection rather than pushing premium volume.James River Group Financial Statement Overview
Summary
Income Statement
58
Neutral
Balance Sheet
64
Positive
Cash Flow
34
Negative
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 653.21M | 687.61M | 707.63M | 812.01M | 661.51M | 609.03M |
| Gross Profit | 299.92M | 194.97M | 87.29M | 239.22M | 171.06M | -5.03M |
| EBITDA | 41.24M | 74.60M | -47.16M | 111.07M | 68.19M | -94.49M |
| Net Income | 30.57M | 47.43M | -81.12M | -107.68M | 30.97M | -172.80M |
Balance Sheet | ||||||
| Total Assets | 0.00 | 4.86B | 5.01B | 5.32B | 5.14B | 4.95B |
| Cash, Cash Equivalents and Short-Term Investments | 0.00 | 888.10M | 979.45M | 1.67B | 1.43B | 2.00B |
| Total Debt | 0.00 | 329.86M | 304.86M | 326.36M | 326.36M | 366.36M |
| Total Liabilities | 4.12B | 4.19B | 4.41B | 4.64B | 4.44B | 4.22B |
| Stockholders Equity | 522.60M | 671.27M | 594.03M | 679.52M | 698.66M | 725.36M |
Cash Flow | ||||||
| Free Cash Flow | -2.31M | -23.59M | -251.97M | 81.52M | 214.51M | -919.85M |
| Operating Cash Flow | 1.75M | -18.79M | -247.09M | 87.95M | 222.73M | -913.55M |
| Investing Cash Flow | -36.18M | -116.04M | 307.03M | 16.73M | -328.15M | 35.82M |
| Financing Cash Flow | -10.72M | 13.20M | -28.85M | -21.11M | 89.67M | 147.67M |
James River Group Technical Analysis
Negative
4.71
Price Trends
4.36
Positive
4.95
Negative
5.59
Negative
Market Momentum
0.06
Positive
49.02
Neutral
68.65
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JRVR, the sentiment is Negative. The current price of 4.71 is above the 20-day moving average (MA) of 4.60, above the 50-day MA of 4.36, and below the 200-day MA of 5.59, indicating a neutral trend. The MACD of 0.06 indicates Positive momentum. The RSI at 49.02 is Neutral, neither overbought nor oversold. The STOCH value of 68.65 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JRVR.
James River Group Risk Analysis
James River Group disclosed 54 risk factors in its most recent earnings report. James River Group reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
James River Group Peers Comparison
UnderperformOutperform
Sector (68)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | $547.22M | 13.35 | 14.03% | 3.71% | 8.67% | 21.89% | |
73 Outperform | $539.77M | 11.26 | 18.37% | 8.55% | 9.54% | -5.60% | |
68 Neutral | $674.78M | -150.58 | 68.25% | 1.35% | -73.08% | -226.17% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
59 Neutral | $217.31M | 8.42 | 4.93% | 0.85% | -1.78% | ― | |
45 Neutral | $260.69M | -1.73 | 6.98% | ― | -8.74% | 36.99% |
* Financial Sector Average
JRVR
James River Group
4.54
-1.17
-20.45%
AMSF
Amerisafe
28.14
-14.25
-33.62%
ITIC
Investors Title Company
285.83
56.05
24.39%
MBI
MBIA
5.03
-1.33
-20.91%
TIPT
Tiptree Financial
18.07
-4.46
-19.80%
James River Group Corporate Events
Business Operations and StrategyDividendsFinancial Disclosures
James River Group Posts Stronger Q2 2026 Earnings Performance
Positive
Aug 10, 2026
In its second-quarter 2026 results released on August 10, James River reported net income available to common shareholders of $4.4 million, up 59% from the same period in 2025, and tangible common equity per share of $9.01. The Board also declared...
Legal Proceedings
James River Group Advances Direct Damages Claim in Court
Neutral
Jun 17, 2026
On June 13, 2026, the Supreme Court of the State of New York, Commercial Division, partly granted and partly denied Fleming Intermediate Holdings LLC’s motion to dismiss James River Group Holdings, Inc.’s amended complaint over Fleming...
Executive/Board Changes
James River Group Adds Independent Director to Board
Positive
Jun 8, 2026
James River Group Holdings has announced changes to its board, with long-serving director Dennis J. Langwell notifying the company on April 8, 2026 that he would not seek re-election and subsequently resigning effective June 16, 2026, without any ...
Business Operations and StrategyFinancial Disclosures
James River Highlights Profit-Focused Q1 2026 E&S Performance
Positive
May 12, 2026
In May 2026, James River Group furnished its first quarter 2026 investor presentation, highlighting a leading specialty insurer franchise with $1.1 billion in gross written premium over the last twelve months, $518 million in total shareholders...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.